Biolaborid OÜ
Active Registry code 11879691
OÜ Tallinn Registered 18 Jan 2010
Biolaborid OÜ is a OÜ based in Tallinn, registry code 11879691, status: active. Main activity: Research and experimental development on biotechnology. According to EMTA, turnover for Q3 2026 was €0 with employees.
Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Revenue · 2024 0 €above 5% of companiesindustry median 0 € · companies in the industry: 1 053
Taxes and turnover
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | — | — | — | — |
| Q2 2026 | — | — | — | — |
| Q1 2026 | — | 328 | 342 | — |
| Q4 2025 | — | 493 | 513 | 1 |
| Q3 2025 | — | 492 | 513 | 1 |
| Q2 2025 | — | 492 | 513 | 1 |
| Q1 2025 | — | 487 | 508 | 1 |
| Q4 2024 | — | 474 | 496 | 1 |
| Q3 2024 | — | 474 | 496 | 1 |
| Q2 2024 | — | 772 | 798 | 1 |
| Q1 2024 | — | 1 031 | 1 061 | 1 |
| Q4 2023 | — | 1 010 | 1 028 | 2 |
| Q3 2023 | 318 000 | 55 551 | 1 099 | 2 |
| Q2 2023 | 27 000 | 3 341 | 1 760 | 2 |
| Q1 2023 | 27 000 | 2 851 | 1 760 | 2 |
| Q4 2022 | 27 000 | 5 906 | 1 332 | 2 |
| Q3 2022 | 27 000 | 4 841 | 1 602 | 2 |
| Q2 2022 | 27 000 | 4 815 | 606 | 2 |
| Q1 2022 | 27 000 | 4 883 | 872 | — |
Financials by year
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2024 | 0 | -13 843 | 5 815 | 113 527 | 112 923 | 1 |
| 2023 | 63 000 | -132 875 | 10 437 | 131 350 | 125 900 | 1 |
| 2022 | 108 000 | -46 526 | 10 436 | 558 181 | 127 594 | 1 |
| 2021 | 108 000 | 22 916 | 10 217 | 598 788 | 174 120 | 1 |
| 2020 | 108 000 | 25 847 | 10 436 | 510 184 | 116 004 | 1 |
| 2019 | 108 000 | 19 764 | 10 436 | 480 098 | 84 158 | 1 |
| 2018 | — | — | — | — | — | 1 |
| 2017 | — | — | — | — | — | 3 |
| 2016 | — | — | — | — | — | 3 |
| 2015 | — | — | — | — | — | 1 |
| 2014 | — | — | — | — | — | 1 |
| 2013 | — | — | — | — | — | 0 |
| 2012 | — | — | — | — | — | 0 |
| 2011 | — | — | — | — | — | 0 |
| 2010 | — | — | — | — | — | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2024
Return on equity (ROE)
-12.3 %
Net profit / equity
Return on assets (ROA)
-12.2 %
Net profit / assets
Equity ratio
99.5 %
Equity / assets
Debt ratio
0.5 %
Liabilities / assets
Current ratio
187.37
Current assets / current liabilities
Revenue per employee
0 €
Revenue / average full-time employees
Labour cost per employee per month
485 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 10 Oct 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 8 Jul 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 18 Jul 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 6 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 10 May 2022 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 30 Oct 2020 | Company’s own | e-Äriregister |
Board
- Ivar JärvingBoard member · since 16 May 2018
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- OÜ Cellin TechnologiesLegal person · 11543666 · 82 511 €
- AS Taastava Kirurgia KliinikLegal person · 10286204 · 31 745 €
- MEDCO PARTNERS OSAÜHINGLegal person · 10860152 · 745 €
Beneficial owners
- Andrus LoogMember of a senior management body (management or supervisory board) · since 21 Oct 2018
- Ivar JärvingMember of a senior management body (management or supervisory board) · since 21 Oct 2018
- Tiit MerenIndirect ownership · since 21 Oct 2018
Founders and other persons
- Osaühing ProtoBioSFounder · 40 000 € · 18 Jan 2010
- Sergei TšistjakovAudit firm · 15 Oct 2020
- Andrus LoogChairman of the supervisory board · 29 Aug 2021
- Ivari SaarSupervisory board member · 15 Sep 2023
Related companies
Activities (EMTAK)
- 72111Research and experimental development on biotechnology Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10142038 / M20 19 Oct 2026 |
Warning of deletion from the register: annual report not filed | 22 Jan 2027 | In force 19 Oct 2026 |
|
| Ä 10142038 / 25 14 Mar 2024 |
Amendment entry | In force 14 Mar 2024 |
||
| Ä 10142038 / 24 12 Dec 2023 |
Amendment entry | In force 12 Dec 2023 |
||
| Ä 10142038 / 23 10 Oct 2023 |
Amendment entry | In force 10 Oct 2023 |
||
| Ä 10142038 / 22 2 Sep 2023 |
Amendment entry | In force 2 Sep 2023 |
||
| Ä 10142038 / 21 13 Oct 2020 |
Amendment entry | In force 13 Oct 2020 |
||
| Ä 10142038 / M19 23 Sep 2020 |
Ruling to eliminate deficiencies | 7 Oct 2020 | Deficiencies eliminated 13 Oct 2020 |
|
| Ä 10142038 / 20 8 Jul 2019 |
Amendment entry | In force 8 Jul 2019 |
||
| Ä 10142038 / 19 5 Apr 2019 |
Amendment entry | In force 5 Apr 2019 |
||
| Ä 10142038 / 18 30 Nov 2018 |
Amendment entry | In force 30 Nov 2018 |
||
| Ä 10142038 / 17 30 Nov 2018 |
Entry refused: deficiencies not eliminated | In force 28 Dec 2018 |
||
| Ä 10142038 / M18 31 Oct 2018 |
Ruling to eliminate deficiencies | 3 Nov 2018 | In force 31 Oct 2018 |
|
| Ä 10142038 / M17 17 Oct 2018 |
Ruling to eliminate deficiencies | 1 Nov 2018 | In force 17 Oct 2018 |
|
| Ä 10142038 / 16 16 May 2018 |
Amendment entry | In force 16 May 2018 |
||
| Ä 10142038 / M16 26 Apr 2018 |
Ruling to eliminate deficiencies | 16 May 2018 | Deficiencies eliminated 16 May 2018 |
|
| Ä 10142038 / 15 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 10142038 / 14 1 Dec 2017 |
Amendment entry | In force 1 Dec 2017 |
||
| Ä 10142038 / 13 17 Aug 2017 |
Amendment entry | In force 17 Aug 2017 |
||
| Ä 10142038 / M15 14 Aug 2017 |
Ruling to eliminate deficiencies | 29 Aug 2017 | Deficiencies eliminated 17 Aug 2017 |
|
| Ä 10142038 / M14 31 Jul 2017 |
Ruling to eliminate deficiencies | 20 Aug 2017 | Deficiencies eliminated 17 Aug 2017 |
|
| Ä 10142038 / 12 20 Jun 2017 |
Entry refused: deficiencies not eliminated | In force 2 Aug 2017 |
||
| Ä 10142038 / M13 29 May 2017 |
Ruling to eliminate deficiencies | 18 Jun 2017 | In force 29 May 2017 |
|
| Ä 10142038 / M12 10 May 2017 |
Procedural ruling | In force 10 May 2017 |
||
| Ä 10142038 / 11 16 Feb 2017 |
Entry refused: deficiencies not eliminated | In force 28 Mar 2017 |
||
| Ä 10142038 / M11 31 Jan 2017 |
Ruling to eliminate deficiencies | 14 Feb 2017 | In force 31 Jan 2017 |
|
| Ä 10142038 / 10 12 Jan 2017 |
Amendment entry | In force 12 Jan 2017 |
||
| Ä 10142038 / M10 6 Jan 2017 |
Ruling to eliminate deficiencies | 31 Jan 2017 | Deficiencies eliminated 12 Jan 2017 |
|
| Ä 10142038 / M9 30 Dec 2016 |
Ruling to eliminate deficiencies | 29 Jan 2017 | Deficiencies eliminated 12 Jan 2017 |
|
| Ä 10142038 / M8 30 Nov 2016 |
Ruling to eliminate deficiencies | 30 Dec 2016 | Deficiencies eliminated 12 Jan 2017 |
|
| Ä 10142038 / 9 11 Jun 2015 |
Amendment entry | In force 11 Jun 2015 |
||
| Ä 10142038 / 8 3 Feb 2014 |
Entry refused: deficiencies not eliminated | In force 18 Feb 2014 |
||
| Ä 10142038 / M7 13 Sep 2013 |
Procedural ruling | In force 13 Sep 2013 |
||
| Ä 10142038 / 7 30 Aug 2013 |
Amendment entry | In force 30 Aug 2013 |
||
| Ä 10142038 / M6 29 Aug 2013 |
Ruling to eliminate deficiencies | 28 Sep 2013 | In force 29 Aug 2013 |
|
| Ä 10142038 / M5 19 Jul 2013 |
Ruling to eliminate deficiencies | 18 Aug 2013 | In force 19 Jul 2013 |
|
| Ä 10142038 / 6 24 Apr 2013 |
Amendment entry | In force 24 Apr 2013 |
||
| Ä 10142038 / M4 15 Apr 2013 |
Ruling to eliminate deficiencies | 15 May 2013 | Deficiencies eliminated 24 Apr 2013 |
|
| Ä 10142038 / 5 8 Jun 2011 |
Amendment entry | In force 8 Jun 2011 |
||
| Ä 10142038 / M3 1 Jun 2011 |
Ruling to eliminate deficiencies | 1 Jul 2011 | In force 1 Jun 2011 |
|
| Ä 10142038 / 4 25 May 2011 |
Amendment entry | In force 25 May 2011 |
||
| Ä 10142038 / 3 23 Feb 2011 |
Amendment entry | In force 23 Feb 2011 |
||
| Ä 10142038 / M2 16 Feb 2011 |
Ruling to eliminate deficiencies | 7 Mar 2011 | In force 16 Feb 2011 |
|
| Ä 10142038 / M1 8 Feb 2011 |
Ruling to eliminate deficiencies | 7 Mar 2011 | In force 8 Feb 2011 |
|
| Ä 10142038 / 2 5 Jan 2011 |
Amendment entry | In force 5 Jan 2011 |
||
| Ä 142038 18 Jan 2010 |
First entry | In force 18 Jan 2010 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data